What is Dural Enhancement?

Dural enhancement refers to the abnormal appearance of the dura mater on magnetic resonance imaging (MRI) after the administration of a contrast agent, typically gadolinium. The dura mater is the outermost layer of the meninges, the protective membranes covering the brain and spinal cord. In a healthy state, the dura does not normally enhance significantly. When it does, it signals an underlying pathological process that may involve inflammation, infection, neoplasia, or other conditions.

Common Causes of Dural Enhancement

The spectrum of causes for dural enhancement is broad. Keywords to consider include: meningitis, intracranial hypotension, metastases, granulomatous disease, and post-surgical changes. Infectious etiologies such as bacterial or tuberculous meningitis often lead to diffuse dural enhancement along the convexities or base of the skull. In contrast, intracranial hypotension, often due to spontaneous CSF leak, classically presents with diffuse, thick, pachymeningeal enhancement. Neoplastic involvement, such as dural metastases from breast or lung cancer, may appear as nodular or focal dural enhancement.

MRI Characteristics and Patterns

On T1-weighted post-contrast sequences, dural enhancement can be categorized as pachymeningeal (thickening of the dura) or leptomeningeal (involvement of the pia-arachnoid). Pachymeningeal enhancement is typically linear, smooth, and follows the inner table of the skull. It is important to differentiate this from leptomeningeal enhancement, which extends into the sulci and cisterns. Associated findings such as subdural hygromas or effusions may also be present in cases of intracranial hypotension.

Clinical Correlations and Diagnostic Approach

When dural enhancement is identified, a thorough clinical history is paramount. Key symptoms include positional headache (suggesting intracranial hypotension), fever and neck stiffness (suggesting meningitis), or known malignancy. Cerebrospinal fluid analysis, including cultures and cytology, is often necessary. Advanced MRI techniques, such as high-resolution T1 sequences with fat suppression, may improve detection of subtle dural enhancement, especially in the spine.

Management Implications

Treatment depends entirely on the underlying cause. For infectious meningitis, appropriate antibiotics or antivirals are required. Intracranial hypotension may be managed with conservative measures, epidural blood patches, or surgical repair of CSF leaks. Dural metastases often require radiation or systemic therapy. In all cases, timely recognition and interpretation of dural enhancement are critical to guide appropriate interventions.